Welcome to Dwaey, specifically on Trimebutine Maleate page.
This medicine contains important and useful components, as it consists of
Trimebutine Maleate is available in the market in concentration.
Trimebutine Maleate
Before starting Trimebutine Maleate, it is important for patients to consult with their healthcare provider to ensure the medication is appropriate for their health condition. Below are key precautions to be aware of:
- Gastrointestinal Disorders: Trimebutine is commonly used to treat gastrointestinal issues such as irritable bowel syndrome (IBS) and other functional GI disorders. However, caution should be exercised in patients with severe gastrointestinal obstruction or conditions that may cause bowel perforation, such as megacolon.
- Hepatic Impairment: Patients with liver diseases should use Trimebutine with caution. Hepatic dysfunction can affect the metabolism of the drug, increasing the risk of side effects. Dose adjustments may be necessary.
- Renal Impairment: Caution is also needed for patients with renal problems as the drug may be excreted via the kidneys. Adjustments in dose or more careful monitoring may be required.
- Pregnancy and Breastfeeding: Trimebutine Maleate is classified as Category C during pregnancy, which means its safety during pregnancy has not been fully established. It should only be used when the potential benefits outweigh the risks. The drug is not recommended for use while breastfeeding due to the lack of data on its excretion in breast milk.
- Elderly Patients: Older adults may be more sensitive to the drug's effects, particularly in terms of gastrointestinal function. Monitoring for any adverse effects like abdominal discomfort, diarrhea, or constipation is important.
Trimebutine Maleate is primarily used for the treatment of gastrointestinal disorders due to its ability to regulate the motility of the digestive tract. Key indications include:
- Irritable Bowel Syndrome (IBS): Trimebutine is commonly prescribed to manage the symptoms of IBS, including abdominal pain, bloating, diarrhea, and constipation. It helps by modulating the muscle contractions of the intestines, improving motility.
- Functional Gastrointestinal Disorders: It is used in the management of functional GI disorders where the digestive system doesn’t function properly but there is no obvious structural cause. It can help normalize the intestinal motility and alleviate symptoms such as cramps and bloating.
- Acute and Chronic Gastrointestinal Pain: It is used for the relief of acute and chronic abdominal pain caused by spasticity in the gut, particularly in conditions such as gastritis, enteritis, and colitis.
- Diarrhea and Constipation: It is sometimes prescribed for managing chronic diarrhea and constipation in certain patients due to its ability to regulate intestinal contractions.
Trimebutine Maleate should be avoided in the following situations:
- Hypersensitivity: Patients who have known allergies to Trimebutine or any of its components should avoid using the medication.
- Severe Gastrointestinal Obstruction: The drug should not be used in patients with severe mechanical obstruction of the intestines as it could worsen the condition.
- Peritonitis: Trimebutine should be avoided in patients with peritonitis or those undergoing abdominal surgery due to the risk of worsening or interfering with gastrointestinal healing.
- Children Under 12: The safety and efficacy of Trimebutine in children under 12 years of age have not been established, and its use in this population is generally not recommended unless prescribed by a healthcare provider for specific conditions.
- Severe Liver or Renal Failure: Trimebutine should be contraindicated in patients with severe hepatic or renal impairment, as the drug’s metabolism or excretion may be significantly impaired, leading to toxicity.
Like all medications, Trimebutine Maleate can cause side effects, ranging from mild to severe:
- Common Side Effects:
- Abdominal Discomfort: Mild stomach cramps or discomfort may occur, especially during the initial phase of treatment.
- Constipation or Diarrhea: Depending on the individual’s response, Trimebutine can cause either constipation or diarrhea. These symptoms may resolve with time or adjustment of the dose.
- Nausea or Vomiting: Some individuals may experience nausea or, less commonly, vomiting after taking the medication.
- Dizziness or Fatigue: These may occur, particularly when adjusting to the medication.
- Serious Side Effects:
- Severe Abdominal Pain: While rare, severe abdominal pain or bloating may indicate an adverse reaction or the presence of an underlying condition.
- Allergic Reactions: Symptoms like rash, itching, swelling, or difficulty breathing could indicate a serious allergic reaction, requiring immediate medical attention.
- Liver or Kidney Problems: If you experience yellowing of the skin or eyes, unusual fatigue, or dark urine, this could indicate a problem with liver function and should be reported to a doctor immediately.
Patients should report any unusual symptoms or side effects to their healthcare provider.
Trimebutine Maleate is a muscle relaxant and antispasmodic agent that works by modulating gastrointestinal motility. Specifically:
- Dual Mechanism: Trimebutine has a dual mechanism of action. It acts both as an agonist and antagonist on opioid receptors in the gut, which regulates motility. It relaxes overactive muscles in the gastrointestinal tract and improves the coordination of muscle contractions, helping to relieve symptoms like abdominal pain and bloating.
- Intestinal Motility Regulation: Trimebutine helps to normalize the motor activity of the digestive tract, thus easing symptoms of both diarrhea and constipation in conditions like irritable bowel syndrome (IBS).
- Reduction of Spasms: It also inhibits smooth muscle spasms in the intestines, which is why it is effective in treating functional gastrointestinal disorders like IBS and gastrocolic reflex.
Trimebutine Maleate may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects:
- Central Nervous System (CNS) Depressants: Combining Trimebutine with CNS depressants like benzodiazepines, antidepressants, or opioids may increase the risk of sedation or dizziness. Caution is advised when using these medications concurrently.
- Anticholinergic Medications: Medications that affect the cholinergic system (such as antihistamines, antidepressants, or antipsychotics) may interact with Trimebutine and alter its effects, increasing the risk of side effects like dry mouth, blurred vision, and urinary retention.
- Antacids: Antacids can alter the absorption of Trimebutine by changing the pH level in the stomach, potentially reducing its efficacy. It is recommended to space out the administration of antacids and Trimebutine by at least two hours.
- Other Gastrointestinal Medications: Combining Trimebutine with other gastrointestinal drugs, such as laxatives or anti-diarrheal agents, could result in changes in motility regulation. If such combinations are required, careful monitoring is necessary.
- Food and Alcohol: Alcohol may intensify the sedative effects of Trimebutine, leading to increased drowsiness or dizziness. Patients should limit alcohol consumption while on this medication. Food does not appear to significantly affect the absorption of Trimebutine.
For adults, the typical dosage of Trimebutine Maleate is:
- Initial Dose: The usual starting dose is 100-200 mg taken three times a day before meals.
- Maintenance Dose: Depending on the patient's response, the dose may be adjusted to a maximum of 600 mg/day, divided into three doses.
- Duration of Treatment: The medication should be taken for as long as the healthcare provider recommends. For chronic conditions like IBS, treatment may be continued for several months or longer.
Patients should follow the prescribed dosage and not exceed the recommended amount.
For pediatric patients, Trimebutine Maleate is generally not recommended unless specifically prescribed by a doctor for certain conditions, as its safety and efficacy in children have not been well established. If prescribed:
- For Children Over 12 Years: The dosage is generally similar to that of adults, with 100 mg three times a day before meals. However, it should be administered under medical supervision.
Consultation with a healthcare provider is crucial before starting Trimebutine to ensure it is the appropriate treatment for the child’s condition.
In patients with renal impairment, dose adjustments are recommended for Trimebutine Maleate. While there is no established specific dosing guide for renal failure, caution should be used, and renal function should be regularly monitored. If severe renal insufficiency is present, the dosage may need to be reduced or treatment may need to be reconsidered.
Not available in a medicine form yet